Page 34 - RxBound Winter 2015 Extended
P. 34
Emmanuelle Schwartzman Padhukasahasram B, Li J, Langholz D, Communication Pearls for
• Led the recruitment efforts during the Tang W, Williams K, Sabbah HN. Pharmacists” (pp 26-30). California
residency showcase booth at the “Genetic and Non-Genetic Factors Pharmacist. Summer 2014
California Health-System Pharmacist Influencing Pharmacokinetics of B-type • DenetClaw TH, Young EW, Tiemeier
Seminar (CSHP). San Francisco, CA, Natriuretic Peptide.” J Card Fail. 2014 AM, Scott JD, Hartzler ML.
October 2014 Sep;20(9):662-8 PMID 24983826 “Perceptions, Obstacles, and
• Perugu S, Rehan V, Chow SL, Baylen Solutions for Offering Introductory
Gollapudi Shankar B. “Plasma Biomarkers and Pharmacy Practice Experiences in the
• Represented WesternU on the Echocardiographic Indices of Left Community Hospital Setting: A
Professional Affairs Committee at the Ventricular Function in Very Low Birth Qualitative Study.” Currents in
California Health-System Pharmacist Weight Infants.” In press, Journal of Pharmacy Learning and Teaching,
Seminar. San Francisco, CA, October Neonatal-Perinatal Medicine 2014, 6:632-8
2014 • Jackevicius CA, Co MJ, Warner A. • GS Shankar “Serotonergic
• Participated with the Certification “Predictors of erythropoietin use in Projections: Religiosity and Hyper-
Committee that discussed addition of patients with cardio renal anemia Religiosity.” J Autacoids 3: e123. doi:
more clinical areas for board syndrome.” Int J Pharm Pract 2014; 10.4172/2161-0479.1000e123
certification and possible deletion of doi: 10.1111/ijpp.12133 • Vu D, Sakharkar P, Shah T, Naraghi
additional qualifications during the • Jackevicius CA, Glassman P. R, Yasir Q, Hutchinson IV, Min DI.
American College of Clinical “Laboratory monitoring for Association of Interferon-γ Cytokine
Pharmacy (ACCP) Meeting. Austin, pharmaceuticals: familiarity does not Gene Polymorphisms with BK Virus
TX, October 2014 breed contempt.” J Gen Intern Med Nephropathy in a Hispanic Renal
• Appointed to the 2015 Committee on 2014; DOI: 10.1007/s11606-014- Allograft Recipients. Transplantation,
Professional Affairs of the California 3048-x 2014;97:660-667
Society of Health-System Pharmacists • Davis E, Packard A, Jackevicius CA.
and the ACCP Certification Affairs “The Pharmacist Role in Predicting
Committee for 2015 and Improving Medication Adherence Expanded Content
Jeffery Wang in Heart Failure Patients.” J Manag
Care Pharm. 2014;20(7):741-55
• Invited to be part of the NIH • Law A, Zapata A, Bik T “Clinical Presentations
Botanical Dietary Supplement Practice Capsule: Patient-Centered Jaejin An
Research Centers (BDSRC) (P50) Labeling: How to Make Prescription • “Lipid Control and Cardiovascular
Review Meeting organized by the Labels Work for our Patients.” (pp 35- Risk for Patients with Rheumatoid
National Center for Complementary 38) California Pharmacist. Summer Arthritis Compared with Matched
and Alternative Medicine 2014 Non-Rheumatoid Arthritis Patients.”
(NCCAM/NIH) and the Office of • Zhang Y-L, Yang K-W, Zhou Y-J, American College of Rheumatology
Dietary Supplements (ODS/NIH)
LaCuran AE, Oelschlaeger P, Crowder Annual Meeting. Boston, MA,
MW. “Diaryl-Substituted November 2014
Publications Azolylthioacetamides: Inhibitor • “Traditional Cardiovascular Risk-
• Lung S, Cassee FR, Gosens I, Campbell Discovery of New Delhi Metallo-β- Factor Management in Patients with
A. “Brain suppression of AP-1 by Lactamase-1 (NDM-1).” Rheumatoid Arthritis Compared with
inhaled diesel exhaust and reversal by ChemMedChem. 2014;9(11):2445-8. Matched Non-Rheumatoid Arthritis
cerium oxide nanoparticles.” Inhal doi: 10.1002/cmdc.201402249 Patients in a US Managed Care
Toxicol. 2014 Aug;26(10):636-641 • Pegg KM, Liu EM, George AC, Setting.” American College of
• Campbell A, Daher N, Solaimani P, LaCuran AE, Bethel CR, Bonomo RA, Rheumatology Annual Meeting,
Mendoza K, Sioutas C. “Human brain Oelschlaeger P. “Understanding the Boston, MA, November 2014
derived cells respond in a type-specific determinants of substrate specificity in Roger Klotz
manner after exposure to urban IMP family metallo-β-lactamases: The • Presentation on “ICU Total Parenteral
particulate matter (PM).” Toxicology importance of residue 262.” Protein Nutrition” and workshop discussion
in Vitro. 2014;28(7):1290-5 Science. 2014;23(10): 1451-60. doi: of “Nutritional Assessment.”
• Chang A, Yeung S, Thakkar A, Huang 10.1002/pro.2530 Intensive Care Unit Clinical Pharmacy
KM, Liu MM, Kanassatega R, Parsa • Pon D, Abe A and Gupta E. “A Conference and Workshop at First
C, Orlando R, Jackson EK, Andresen Review of Statin Use and Prostate Affiliated Hospital, Sun Yat-sen
BT, Huang Y. Prevention of Skin Cancer.” Curr Atheroscler Rep (2015) University, Guangzhou, China,
Carcinogenesis by the β-Blocker 17:474. DOI 10.1007/s11883-014- September, 2014
Carvedilol. Cancer Prev Res (Phila). 0474-5 • Presentation on Pharmacist and
2014 Nov 3 • Schwartzman EM, Kleyn TJ Physician Collaborative Hypertension
• Lanfear DE, Chow SL, “Transgender Patients:
32 WesternU, College of Pharmacy
• Led the recruitment efforts during the Tang W, Williams K, Sabbah HN. Pharmacists” (pp 26-30). California
residency showcase booth at the “Genetic and Non-Genetic Factors Pharmacist. Summer 2014
California Health-System Pharmacist Influencing Pharmacokinetics of B-type • DenetClaw TH, Young EW, Tiemeier
Seminar (CSHP). San Francisco, CA, Natriuretic Peptide.” J Card Fail. 2014 AM, Scott JD, Hartzler ML.
October 2014 Sep;20(9):662-8 PMID 24983826 “Perceptions, Obstacles, and
• Perugu S, Rehan V, Chow SL, Baylen Solutions for Offering Introductory
Gollapudi Shankar B. “Plasma Biomarkers and Pharmacy Practice Experiences in the
• Represented WesternU on the Echocardiographic Indices of Left Community Hospital Setting: A
Professional Affairs Committee at the Ventricular Function in Very Low Birth Qualitative Study.” Currents in
California Health-System Pharmacist Weight Infants.” In press, Journal of Pharmacy Learning and Teaching,
Seminar. San Francisco, CA, October Neonatal-Perinatal Medicine 2014, 6:632-8
2014 • Jackevicius CA, Co MJ, Warner A. • GS Shankar “Serotonergic
• Participated with the Certification “Predictors of erythropoietin use in Projections: Religiosity and Hyper-
Committee that discussed addition of patients with cardio renal anemia Religiosity.” J Autacoids 3: e123. doi:
more clinical areas for board syndrome.” Int J Pharm Pract 2014; 10.4172/2161-0479.1000e123
certification and possible deletion of doi: 10.1111/ijpp.12133 • Vu D, Sakharkar P, Shah T, Naraghi
additional qualifications during the • Jackevicius CA, Glassman P. R, Yasir Q, Hutchinson IV, Min DI.
American College of Clinical “Laboratory monitoring for Association of Interferon-γ Cytokine
Pharmacy (ACCP) Meeting. Austin, pharmaceuticals: familiarity does not Gene Polymorphisms with BK Virus
TX, October 2014 breed contempt.” J Gen Intern Med Nephropathy in a Hispanic Renal
• Appointed to the 2015 Committee on 2014; DOI: 10.1007/s11606-014- Allograft Recipients. Transplantation,
Professional Affairs of the California 3048-x 2014;97:660-667
Society of Health-System Pharmacists • Davis E, Packard A, Jackevicius CA.
and the ACCP Certification Affairs “The Pharmacist Role in Predicting
Committee for 2015 and Improving Medication Adherence Expanded Content
Jeffery Wang in Heart Failure Patients.” J Manag
Care Pharm. 2014;20(7):741-55
• Invited to be part of the NIH • Law A, Zapata A, Bik T “Clinical Presentations
Botanical Dietary Supplement Practice Capsule: Patient-Centered Jaejin An
Research Centers (BDSRC) (P50) Labeling: How to Make Prescription • “Lipid Control and Cardiovascular
Review Meeting organized by the Labels Work for our Patients.” (pp 35- Risk for Patients with Rheumatoid
National Center for Complementary 38) California Pharmacist. Summer Arthritis Compared with Matched
and Alternative Medicine 2014 Non-Rheumatoid Arthritis Patients.”
(NCCAM/NIH) and the Office of • Zhang Y-L, Yang K-W, Zhou Y-J, American College of Rheumatology
Dietary Supplements (ODS/NIH)
LaCuran AE, Oelschlaeger P, Crowder Annual Meeting. Boston, MA,
MW. “Diaryl-Substituted November 2014
Publications Azolylthioacetamides: Inhibitor • “Traditional Cardiovascular Risk-
• Lung S, Cassee FR, Gosens I, Campbell Discovery of New Delhi Metallo-β- Factor Management in Patients with
A. “Brain suppression of AP-1 by Lactamase-1 (NDM-1).” Rheumatoid Arthritis Compared with
inhaled diesel exhaust and reversal by ChemMedChem. 2014;9(11):2445-8. Matched Non-Rheumatoid Arthritis
cerium oxide nanoparticles.” Inhal doi: 10.1002/cmdc.201402249 Patients in a US Managed Care
Toxicol. 2014 Aug;26(10):636-641 • Pegg KM, Liu EM, George AC, Setting.” American College of
• Campbell A, Daher N, Solaimani P, LaCuran AE, Bethel CR, Bonomo RA, Rheumatology Annual Meeting,
Mendoza K, Sioutas C. “Human brain Oelschlaeger P. “Understanding the Boston, MA, November 2014
derived cells respond in a type-specific determinants of substrate specificity in Roger Klotz
manner after exposure to urban IMP family metallo-β-lactamases: The • Presentation on “ICU Total Parenteral
particulate matter (PM).” Toxicology importance of residue 262.” Protein Nutrition” and workshop discussion
in Vitro. 2014;28(7):1290-5 Science. 2014;23(10): 1451-60. doi: of “Nutritional Assessment.”
• Chang A, Yeung S, Thakkar A, Huang 10.1002/pro.2530 Intensive Care Unit Clinical Pharmacy
KM, Liu MM, Kanassatega R, Parsa • Pon D, Abe A and Gupta E. “A Conference and Workshop at First
C, Orlando R, Jackson EK, Andresen Review of Statin Use and Prostate Affiliated Hospital, Sun Yat-sen
BT, Huang Y. Prevention of Skin Cancer.” Curr Atheroscler Rep (2015) University, Guangzhou, China,
Carcinogenesis by the β-Blocker 17:474. DOI 10.1007/s11883-014- September, 2014
Carvedilol. Cancer Prev Res (Phila). 0474-5 • Presentation on Pharmacist and
2014 Nov 3 • Schwartzman EM, Kleyn TJ Physician Collaborative Hypertension
• Lanfear DE, Chow SL, “Transgender Patients:
32 WesternU, College of Pharmacy
